Leflunomide-related lung injury in patients with rheumatoid arthritis: Imaging features

Modern Rheumatology

Volumn 15, Issue 3, 2005, Pages 173-179

  Sakai, Fumikazu ^a,c   Noma, Satoshi ^a,d   Kurihara, Yasuyuki ^a,e   Yamada, Hidehiro ^a,e   Azuma, Arata ^a,f   Kudoh, Shoji ^a,f   Ichikawa, Youichi ^b,g  

^a Arava External Safety Review Board   (Japan)

^b Arava External Safety Review Board   (Japan)

^c TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^d TENRI HOSPITAL   (Japan)

^e ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f NIPPON MEDICAL SCHOOL   (Japan)

^g St Joseph Hospital   (Japan)

Author keywords

Computed tomography (CT); Diffuse alveolar damage (DAD); Leflunomide; Lung injury

Indexed keywords

LEFLUNOMIDE;

ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION FUNCTION; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; FIBROSING ALVEOLITIS; HUMAN; INTERSTITIAL LUNG DISEASE; LOEFFLER PNEUMONIA; LUNG INJURY; LUNG SCINTISCANNING; MAJOR CLINICAL STUDY; MORTALITY; ORGANIZING PNEUMONIA; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; THORAX RADIOGRAPHY;

EID: 22144446840     PISSN: 14397595     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10165-005-0387-9     Document Type: Article

References (43)

1. Cannon GW, Kremer JM. Leflunomide. Lancet 2004;363:1239-40.
2. Leung H, Hurley F, Strand V. Issues involved in a metaanalysis of rheumatoid arthritis radiographic progression. Analysis issues. J Rheumatol 2000;27:544-8.
3. Sharp JT, Strand V, Leung H, Hurley F, Loew-Friedrich I. Treatment with leflunomide slows radiographic progression of rheumatoid arthritis: results from three randomized controlled trials of leflunomide in patients with active rheumatoid arthritis. Leflunomide Rheumatoid Arthritis Investigators Group. Arthritis Rheum 2000;43:495-505.
4. Scott DL. Interstitial lung disease and disease modifying antirheumatic drugs. Rheum Dis Clin North Am 2004;30:295-309.
5. McCurry J. Japan deaths spark concerns over arthritis drug. Lancet 2004;363:461.
6. Kudo S, Saijo N, Kubo K, Nagai A, Fukuda Y, Sakai F, et al. Final report of the advisory board of gefitinib (Iressa) induced acute lung injury/ interstitial pneumonitis (in Japanese). Tokyo: Astra Zeneca Co. Ltd. 2003.6.
7. Sakai F, Kusumoto T, Johkoh T. Imaging features of gefitinib-induced lung injury (in Japanese). Nihon Kyobu Rinsho 2003; 62:496-505.
8. Sakai F, Kusumoto T, Johkoh T. Gefitinib induced lung injury (in Japanese). Rinsho Hoshasenn 2004;49:1-8.
9. Ruckemann K, Fairbanks LD, Carrey EA, Hawrylowicz CM, Richards DF, Kirschbaum B, et al. Leflunomide inhibits pyrimidine de novo synthesis in mitogen-stimulated T-lymphocytes from healthy humans. J Biol Chem 1998;273:21682-91.
10. Ferraccioli GF, De Vita S. Leflunomide for active rheumatoid arthritis. Lancet 1999;353:1883.
11. Tugwell P, Wells G, Strand V, Maetzel A, Bombardier C, Crawford B, et al. Clinical improvement as reflected in measures of function and health-related quality of life following treatment with leflunomide compared with methotrexate in patients with rheumatoid arthritis: sensitivity and relative efficiency to detect a treatment effect in a twelve-month, placebo-controlled trial. Leflunomide Rheumatoid Arthritis Investigators Group. Arthritis Rheum 2000;43:506-14.
12. Smolen JS, Emery P. Efficacy and safety of leflunomide in active rheumatoid arthritis. Rheumatology (Oxford) 2000;39 Suppl 1: 48-56.
13. Cohen S, Cannon GW, Schiff M, Weaver A, Fox R, Olsen N, et al. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group Arthritis Rheum 2001;44:1984-92.
14. Scott DL, Smolen JS, Kalden JR, van de Putte LB, Larsen A, Kvien TK, et al. European Leflunomide Study Group Treatment of active rheumatoid arthritis with leflunomide: Two year follow up of a double blind, placebo controlled trial versus sulfasalazine. Ann Rheum Dis 2001;60:913-23.
15. Jones G, Halbert J, Crotty M, Shanahan EM, Batterham M, Ahern M. The effect of treatment on radiological progression in rheumatoid arthritis: a systematic review of randomized placebocontrolled trials. Rheumatology (Oxford) 2003;42:6-13.
16. Olsen NJ, Stein CM. New drugs for rheumatoid arthritis. N Engl J Med 2004;350:2167-79.
17. Cush JJ. Safety overview of new disease-modifying antirheumatic drugs. Rheum Dis Clin North Am 2004;30:237-55.
18. Smolen JS, Kalden JR, Scott DL, Rozman B, Kvien TK, Larsen A, et al. Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: A double-blind, randomised, multicentre trial. European Leflunomide Study Group. Lancet 1999;353:259-66.
19. Siva C, Eisen SA, Shepherd R, Cunningham F, Fang MA, Finch W, et al. Leflunomide use during the first 33 months after food and drug administration approval: Experience with a national cohort of 3,325 patients. Arthritis Rheum 2003;49:745-51.
20. Suissa S, Ernst P, Hudson M, Bitton A, Kezouh A. Newer disease-modifying antirheumatic drugs and the risk of serious hepatic adverse events in patients with rheumatoid arthritis. Am J Med 2004;117:87-92.
21. Weinblatt ME, Dixon JA, Falchuk KR. Serious liver disease in a patient receiving methotrexate and leflunomide. Arthritis Rheum 2000;43:2609-11.
22. Legras A, Bergemer-Fouquet AM, Jonville-Bera AP. Fatal hepatitis with leflunomide and itraconazole. Am J Med 2002;113:352-3.
23. Gottenberg JE, Venancie PY, Mariette X Alopecia areata in a patient with rheumatoid arthritis treated with leflunomide. J Rheumatol 2002;29:1806-7.
24. van Roon EN, Jansen TL, Houtman NM, Spoelstra P, Brouwers JR. Leflunomide for the treatment of rheumatoid arthritis in clinical practice: Incidence and severity of hepatotoxicity. Drug Saf 2004;27:345-52.
25. Chan J, Sanders DC, Du L, Pillans PI. Leflunomide-associated pancytopenia with or without methotrexate. Ann Pharmacother 2004;38:1206-11.
26. Auer J, Hinterreiter M, Allinger S, Kirchgatterer A, Knoflach P. Severe pancytopenia after leflunomide in rheumatoid arthritis. Acta Med Austriaca 2000:27:131-2.
27. Hill RL, Topliss DJ, Purcell PM. Pancytopenia associated with leflunomide and methotrexate. Ann Pharmacother 2003;37:149.
28. Soliotis F, Glover M, Jawad AS. Severe skin reaction after leflunomide and etanercept in a patient with rheumatoid arthritis. Ann Rheum Dis 2002;61:850-1.
29. Cohen JD, Jorgensen C, Sany J. Leflunomide-induced aseptic meningitis. Joint Bone Spine 2004;71:243-5.
30. Carulli MT, Davies UM. Peripheral neuropathy: An unwanted effect of leflunomide? Rheumatology (Oxford) 2002;41:952-3.
31. Rosenow EC 3rd, Limoer AH. Drug-induced pulmonary diseases. Semin Respir Infect 1995;10:86-95.
32. Rossi SE, Erasmus JJ, MaAdams HP, Sporn TA, Goodman PC. Pulmonary drug toxicity: Radiologic and pathologic manifestations. Radiographics 2000;20:1245-59.
33. Erasmsus JJ, McAdams HP, Rossi SE. High-resolution CT of drug-induced lung diseases. Radiol Clin North Am 2002;40:61-72.
34. Padley SP, Adler B, Hansell DM, Mueller NL. High resolution computed tomography of drug-induced lung diseases. Clin Radiol 1992;46:232-6.
35. Murayama S, Murakami J, Yabuuchi H, Soeda H, Masuda K. Crazy paving appearance on high resolution CT in various lung diseases. J Comput Assist Tomogr 1999;23:749-52.
36. Akira M, Ishikawqa H, Yamamoto S. Drug-induced pneumonitis: Thin section CT findings in 60 patients. Radiology 2002;224:852-60.
37. Ichikado K, Suga M, Muller NL, Taniguchi H, Kondoh Y, Akira M, et al. Acute interstitial pneumonia: Comparison of high-resolution computed tomography findings between survivors and nonsurvivors. Am J Respir Crit Care Med 2002;165: 1551-6.
38. Johkoh T, Muller NL, Taniguchi H, Kondoh Y, Akira M, Ichikado K, et al. Acute interstitial pneumonia: Thin-section CT findings in 36 patients. Radiology 1999;211:859-63.
39. Wong P, Leung AN, Berry GJ, Atkins KA, Montiya JG, Ruoss SJ, et al. Paclitaxel induced hypersensitivity pneumonitis. AJR 2001;176:718-20.
40. Inoue A, Saijo Y, Maemondo M, Gomi K, Tokue Y, Kimura Y, et al. Severe acute interstitial pneumonia and gefitinib. Lancet 2003;61:137-9.
41. Johkoh T, Muller NL, Cartier Y, Kavanagh PV, Hartman TE, Akira M, et al. Idiopathic interstitial pneumonias: Diagnostic accuracy of thin-section CT in 129 patients. Radiology. 1999;211: 555-60.
42. Tomiyama N, Muller NL, Johkoh T, Honda O, Mihara N, Kozuka T, et al. Acute parenchymal lung disease in immunocompetent patients: Diagnostic accuracy of high-resolution CT. AJR 2000;174: 1745-50.
43. Cleverly JR, Sceaton NJ, Hiorns MP, Flint JD, Mueller NL. Drug-induced lung disease: High resolution CT and histologic findings. Clin Radiol 2002;57:292-9.